SmartSense-D: A safety, feasibility, and acceptability pilot study of digital phenotyping in young people with major depressive disorder

SmartSense-D:一项针对重度抑郁症青少年进行数字表型分析的安全性、可行性和接受度试点研究

阅读:1

Abstract

BACKGROUND: Digital assessment of behaviours, including physical activity, sleep, and social interactions could be associated with changes in mood and other mental health symptoms. This study assessed the safety, feasibility, acceptability, and potential predictive value of passive and active sensing in young people with major depressive disorder (MDD). METHODS: Over eight weeks, passive (smartphone sensing, actigraphy) and active (ecological momentary assessment; EMA) data were collected from 40 young participants with MDD (aged 16-25 years). We assessed the safety, feasibility, and acceptability of daily active and passive sensing in this population. Additionally, linear mixed models and correlation analysis explored associations between passive and active sensing measures. RESULTS: Of the 48 young participants, 83% (n = 40) completed the full protocol. No adverse events were reported. Over eight weeks, participants averaged 35.9 days (65.3%) with EMAs and 37.9 days (69%) with actigraphy data. Smartphone sensors recorded communication for 21.1 days (38.4%), location for 43.1 days (78.4%), maximum unlock duration for 43.4 days (79%), social media use for 34.8 days (63.3%), and inter-key delay for 32.8 days (59.6%). Regarding acceptability, 83.1% found the application usable and comfortable. Secondary measures showed significant correlations between sleep and physical activity, and between location and phone use sensors. There was a significant negative association between daily positive mood ratings and QIDS total scores (Beta coefficient [95% CI]: 2.66 [-3.98, -1.34]; p = 0.002). CONCLUSION: Passive and active sensing methods were safe, and acceptable among young people with MDD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。